venlafaxine hydrochloride
venlafaxine hydrochloride is listed in the FDA National Drug Code directory with 49 NDC codes, marketed under brand names including Venlafaxine Hydrochloride, venlafaxine, venlafaxine hydrochloride. Available dosage forms: tablet, capsule, extended release, powder, tablet, extended release.
Drug Details
- Generic Name
- venlafaxine hydrochloride
- Brand Names
- Venlafaxine Hydrochloride, venlafaxine, venlafaxine hydrochloride
- Application Number
- ANDA202036
- Sponsor
- Yaopharma Co., Ltd.
- NDC Codes
- 49
- Dosage Forms
- TABLET, CAPSULE, EXTENDED RELEASE, POWDER, TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- VENLAFAXINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: Major Depressive Disorder (MDD) [see Clinical Studies (14.1) ] Generalized Anxiety Disorder (GAD) [see Clinical Studies (14.2) ] Social Anxiety Disorder (SAD) [see Clinical Studies (14.3) ] Panic Disorder (PD) [see Clinical Studies (14.4) ] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: Major Depressive Disorder ( MDD ) ( 1 ) Generalized Anxiety Disorder ( GAD ) ( 1 ) Social Anxiety Disorder ( SAD ) ( 1 ) Panic Disorder ( PD ) ( 1 )